News

Oncology Central
oncology-central. com-central. com

ASCO 2026: Skipping axillary lymph node dissection safe for some breast cancer patients

10+ hour, 44+ min ago  (322+ words) Oncology Central is part of Taylor & Francis Group. Original story from the ASCO Annual Meeting The trial included 2, 540 people with T1 to T3 breast cancer and up to 2 sentinel lymph node macrometastases. T1 to T3 tumors have not grown into the chest wall or…...

Symbols: cad/usd,tgif.cn,let-h.v,mnrg.ne,mcf.ne,bpai.ne
Oncology Central
oncology-central. com-central. com

ASCO 2026: GLP-1s could reduce the risk of some obesity-related cancers progressing

1+ week, 2+ day ago  (164+ words) Oncology Central is part of Taylor & Francis Group. Original story from the ASCO Annual Meeting Adverse events in the GLP-1 and gliptin groups were similar. Instances of stomach or pancreas inflammation were not higher in the GLP-1 group compared to…...

Symbols: glp-1s,glp-1r,d05.S0,u11.S0,z74.S0,z4d.si
Oncology Central
oncology-central. com-central. com

Call for papers: Breast cancer biomarkers in diagnostic and translational pathology - Breast Cancer: Targets and Therapy

1+ week, 5+ day ago  (117+ words) Oncology Central is part of Taylor & Francis Group. Taylor & Francis is pleased to invite you to submit your work to an upcoming Article Collection on "Breast cancer biomarkers in diagnostic and translational pathology" in the journal Breast Cancer: Targets and…...

Symbols: ebcc-15
Google News
oncology-central. com-central. com

ESMO Breast Cancer Congress 2026: Editor highlights

2+ week, 2+ day ago  (822+ words) Oncology Central is part of Taylor & Francis Group. The 2026 edition of the ESMO Breast Cancer Congress convened leading oncologists, researchers and healthcare professionals from around the world to explore key breakthroughs in breast cancer treatment and care. Held over 3 days,…...

Symbols: btc-usd
Oncology Central
oncology-central. com-central. com

Could GLP-1 receptor agonists improve breast cancer outcomes for patients with obesity or type 2 diabetes?

2+ week, 3+ day ago  (401+ words) Oncology Central is part of Taylor & Francis Group. Original story from the Virginia Commonwealth University Research published recently in JAMA Network Open offers illuminating evidence suggesting there is a positive association between GLP-1 agonists'drugs commonly used to treat obesity and…...

Symbols: glp-1s,glp-1r
Oncology Central
oncology-central. com-central. com

Highlights of the San Antonio Breast Cancer Symposium 2025

2+ week, 5+ day ago  (107+ words) Oncology Central Oncology Central is part of Taylor & Francis Group. Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick…...

Symbols: ebcc-15,btc-usd
Oncology Central
oncology-central. com-central. com

ESMO Breast Cancer 2026: Could retrospective genetic testing improve care for cancer survivors?

3+ week, 2+ day ago  (507+ words) Oncology Central is part of Taylor & Francis Group. Original story from ESMO Breast Cancer 2026 A national study has examined how genetic testing could better inform follow-up care for cancer survivors. Hundreds of thousands of people diagnosed with cancer are still…...

Symbols: btc-usd
Oncology Central
oncology-central. com-central. com

Could ct DNA aid treatment de-escalation for older ER-positive breast cancer patients?

1+ mon, 2+ week ago  (70+ words) Oncology Central Oncology Central is part of Taylor & Francis Group. Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick…...

Symbols: nasdaq:psnl
Oncology Central
oncology-central. com-central. com

DNA methylome test shows promise for multi-cancer detection

1+ mon, 3+ week ago  (795+ words) Oncology Central is part of Taylor & Francis Group. Original story from UCLA UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting multiple cancers, various liver conditions and organ abnormalities simultaneously by…...

Symbols: mced
Oncology Central
oncology-central. com-central. com

ESMO 2025 and new therapies in breast cancer: does society always benefit?

1+ mon, 3+ week ago  (222+ words) Oncology Central Oncology Central is part of Taylor & Francis Group. Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick…...

Symbols: hr,sabcs,mbc